254 Chapter 8 116. Pontiggia; Van Hengel; Klar; et al. Bioprinting and Plastic Compression of Large Pigmented and Vascularized Human Dermo-Epidermal Skin Substitutes by Means of a New Robotic Platform. J. Tissue Eng. 2022, 13, 1–20. 117. Hosseini; Koehler; Shafiee. Biofabrication of Human Skin with Its Appendages. Adv. Healthc. Mater. 2022, 11, 2201626. 118. Vermolen; van Zuijlen. Can Mathematics and Computational Modeling Help Treat Deep Tissue Injuries? Adv. Wound Care 2019, 8, 703–714. 119. van Zuijlen; Korkmaz; Sheraton; et al. The Future of Burn Care From a Complexity Science Perspective. J. Burn Care Res. 2022, 43, 1312–1321. 120. Langendam; Magnuson; Williams; et al. Developing a Database of Systematic Reviews of Animal Studies. Regul. Toxicol. Pharmacol. 2021, 123, 104940. 121. de Vries; Wever; Avey; et al. The Usefulness of Systematic Reviews of Animal Experiments for the Design of Preclinical and Clinical Studies. ILAR J. 2014, 55, 427–437. 122. du Sert; Hurst; Ahluwalia; et al. The Arrive Guidelines 2.0: Updated Guidelines for Reporting Animal Research. PLoS Biol. 2020, 18, 1–12. 123. Vincent; Opal; Marshall; et al. Sepsis Definitions: Time for Change. Lancet 2013, 381, 774–775. 124. Mokline; Garsallah; Rahmani; et al. Procalcitonin: A Diagnostic and Prognostic Biomarker of Sepsis in Burned Patients. Ann. Burns Fire Disasters 2015, 28, 116–120. 125. Hu; Wang; Hong; et al. Admission Neutrophil-Lymphocyte Ratio (NLR) Predicts Survival in Patients with Extensive Burns. Burns 2021, 47, 594–600. 126. Liu; Chu; Kalantar‐Zadeh; et al. Cytokines: From Clinical Significance to Quantification. Adv. Sci. 2021, 8, 2004433. 127. Hampson; Dinsdale; Wearn; et al. Neutrophil Dysfunction, Immature Granulocytes, and Cell-Free DNA Are Early Biomarkers of Sepsis in Burn-Injured Patients: A Prospective Observational Cohort Study. Ann. Surg. 2017, 265, 1241–1249. 128. Jaillon; Ponzetta; Magrini; et al. Europe PMC Funders Group Fluid Phase Recognition Molecules in Neutrophil-Dependent Immune Responses. 2017, 28, 109–118. 129. Strudwick; Cowin. The Role of the Inflammatory Response in Burn Injury. In Hot Topics in Burn Injuries, 2018; 1–128. 130. Honore; Hoste; Molnár; et al. Cytokine Removal in Human Septic Shock: Where Are We and Where Are We Going? Ann. Intensive Care 2019, 9, 56. 131. Wilgus. Inflammation as an Orchestrator of Cutaneous Scar Formation: A Review of the Literature. Plast. Aesthetic Res. 2020, 7, 1–24. 132. Boldeanu; Bogdan; Meca; et al. Immunological Approaches and Therapy in Burns (Review). Exp. Ther. Med. 2020, 20, 2361–2367. 133. Gensler. Glucocorticoids: Complications to Anticipate and Prevent. The Neurohospitalist 2013, 3, 92–97. 134. Coutinho; Chapman. The Anti-Inflammatory and Immunosuppressive Effects of Glucocorticoids, Recent Developments and Mechanistic Insights. Mol. Cell. Endocrinol. 2011, 335, 2–13. 135. Xue; Suarez; Minaai; et al. HMGB1 as a Therapeutic Target in Disease. J. Cell. Physiol. 2021, 236, 3406–3419. 136. Lu; Zhao; Wang; et al. Research Advances in Prevention and Treatment of Burn Wound Deepening in Early Stage. Front. Surg. 2022, 9, 1–7. 137. Shimabukuro-Vornhagen; Gödel; Subklewe; et al. Cytokine Release Syndrome. J. Immunother. Cancer 2018, 6, 56. 138. Toliver-Kinsky; Kobayashi; Suzuki; et al. The Systemic Inflammatory Response Syndrome. In Total Burn Care; Elsevier, 2018; pp. 205–220. 139. Vanlaere; Libert. Matrix Metalloproteinases as Drug Targets in Infections Caused by Gram-Negative Bacteria and in Septic Shock. Clin. Microbiol. Rev. 2009, 22, 224–239. 140. Vanzant; Lopez; Ozrazgat-Baslanti; et al. Persistent Inflammation, Immunosuppression, and Catabolism Syndrome after Severe Blunt Trauma. J. Trauma Acute Care Surg. 2014, 76, 21–30. 141. Nakamori; Park; Shimaoka. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Front. Immunol. 2021, 11, 1–14. 142. Rowan; Cancio; Elster; et al. Burn Wound Healing and Treatment: Review and Advancements. Crit. Care 2015, 19, 1–12. 143. Nielson; Duethman; Howard; et al. Burns: Pathophysiology of Systemic Complications and Current Management. J. Burn Care Res. 2017, 38, e469–e481.
RkJQdWJsaXNoZXIy MTk4NDMw